tradingkey.logo

Movano Inc

MOVE

0.588USD

-0.030-4.81%
Close 09/19, 16:00ETQuotes delayed by 15 min
4.02MMarket Cap
LossP/E TTM

Movano Inc

0.588

-0.030-4.81%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
120 / 207
Overall Ranking
277 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Movano Inc., doing business as Movano Health, is engaged in developing a suite of healthcare solutions to bring medical-grade data to the forefront of wearables. Its devices deliver data to both customers and enterprises, capturing a comprehensive picture of an individual’s health data and translating it into personalized and intelligent insights. Its product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.01M.
Overvalued
The company’s latest PE is -0.15, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 3.25M shares, increasing 12.36% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 375.34K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.92.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 7.33, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is robust, and its operating efficiency is low.

Score

Industry at a Glance

Previous score
7.33
Change
0

Financials

9.45

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

8.12

Operational Efficiency

2.95

Growth Potential

8.80

Shareholder Returns

7.31

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.16, which is 200.38% below the recent high of -0.47 and -11788.58% above the recent low of -18.63.

Score

Industry at a Glance

Previous score
2.80
Change
1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 120/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Movano Inc is 30.00, with a high of 30.00 and a low of 30.00.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

94
Total
4
Median
7
Average
Company name
Ratings
Analysts
Movano Inc
MOVE
1
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 3.82, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 1.09 and the support level at 0.36, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
3.82
Change
-0.04

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.067
Neutral
RSI(14)
41.068
Neutral
STOCH(KDJ)(9,3,3)
4.381
Oversold
ATR(14)
0.135
Low Volatility
CCI(14)
-97.021
Neutral
Williams %R
99.054
Oversold
TRIX(12,20)
0.245
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.657
Sell
MA10
0.710
Sell
MA20
0.781
Sell
MA50
0.701
Sell
MA100
0.725
Sell
MA200
2.371
Sell

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 46.13%, representing a quarter-over-quarter increase of 13.60%. The largest institutional shareholder is Mairs and Power, holding a total of 375.34K shares, representing 4.52% of shares outstanding, with 20.09% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Appel (Peter A)
648.80K
+0.10%
Clayton Partners LLC
143.48K
+27.23%
Mairs and Power, Inc.
Star Investors
375.34K
--
Fairbairn (Malcolm P.)
367.57K
+0.00%
Mastrototaro (John)
96.96K
+398.71%
Cogan (Jeremy D.)
115.03K
+121.03%
Robert W. Baird & Co. Inc.
323.94K
+3.64%
Leabman (Michael Aaron)
76.24K
+2039.11%
Fairbairn Emily Wang
459.88K
+16.58%
Cullinan (Brian)
88.50K
+372.33%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 2.95, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.91. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
2.95
Change
0
Beta vs S&P 500 index
0.91
VaR
--
240-Day Maximum Drawdown
+91.93%
240-Day Volatility
+165.61%
Return
Best Daily Return
60 days
+73.25%
120 days
+73.25%
5 years
--
Worst Daily Return
60 days
-21.41%
120 days
-25.47%
5 years
--
Sharpe Ratio
60 days
+0.59
120 days
-0.52
5 years
--
Risk Assessment
Maximum Drawdown
240 days
+91.93%
3 years
+98.37%
5 years
--
Return-to-Drawdown Ratio
240 days
-0.96
3 years
-0.33
5 years
--
Skewness
240 days
+2.50
3 years
+2.23
5 years
--
Volatility
Realised Volatility
240 days
+165.61%
5 years
--
Standardised True Range
240 days
+43.14%
5 years
--
Downside Risk-Adjusted Return
120 days
-96.15%
240 days
-96.15%
Maximum Daily Upside Volatility
60 days
+253.29%
Maximum Daily Downside Volatility
60 days
+132.51%
Liquidity
Average Turnover Rate
60 days
+37.81%
120 days
+22.34%
5 years
--
Turnover Deviation
20 days
+692.29%
60 days
+234.60%
120 days
+97.71%

Peer Comparison

Healthcare Equipment & Supplies
Movano Inc
Movano Inc
MOVE
5.38 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI